(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
0.36% $ 0.196
Live Chart Being Loaded With Signals
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer...
Stats | |
---|---|
Volumen de hoy | 980 841 |
Volumen promedio | 2.09M |
Capitalización de mercado | 10.66M |
EPS | $0 ( 2024-05-13 ) |
Próxima fecha de ganancias | ( $0 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.150 |
ATR14 | $0.00200 (1.03%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-16 | Soffer Rochel | Sell | 0 | Common Stock |
2024-04-16 | Soffer Rochel | Buy | 0 | Common Stock |
2024-04-19 | Schneid Yair | Buy | 99 371 | Common Stock |
2024-04-19 | Schneid Yair | Buy | 215 | Common Stock |
2024-04-19 | Schneid Yair | Buy | 314 | Common Stock |
INSIDER POWER |
---|
99.84 |
Last 94 transactions |
Buy: 7 261 528 | Sell: 346 527 |
Volumen Correlación
Galera Therapeutics Inc Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Galera Therapeutics Inc Correlación - Moneda/Commodity
Galera Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-259 000 (0.00 %) |
EPS: | $-1.330 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-259 000 (0.00 %) |
EPS: | $-1.330 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-114 000 (0.00 %) |
EPS: | $-2.30 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-3.06 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Galera Therapeutics Inc
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico